Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI class in India, says GlobalData Read more
Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with Cryopyrin-Associated Periodic Syndrome in Australia Read more
Health Minister Mandaviya invites global investors from EXPO2020 to strengthen Make-in-India Read more
European Commission approves Pfizer’s Cibinqo to treat adults with moderate-to-severe atopic dermatitis Read more